This Move Might Reshape the Future of the Chip Industry
Lip-Bu Tan hasn’t been in the driver’s seat at Intel for long, but the new CEO is already making it clear that the era of open-ended spending is over. If Intel’s bleeding-edge chip manufacturing can’t justify its existence with real customer demand, it won’t get more money, period.
That kind of financial discipline might sound like corporate buzzkill,
» Read more about: This Move Might Reshape the Future of the Chip Industry »
Read More
								    				
							    			75 Billion Reasons To Own Google
Alphabet (Google’s parent) has significantly ramped up research and development spending in recent years. In 2022, Google spent about $39.5 billion on R&D, which jumped to $45.4 billion in 2023. This ~15% increase was driven largely by higher personnel costs (adding thousands of engineers) and one-time charges like office space consolidation.
R&D now represents roughly 15% of Google’s annual revenue,
» Read more about: 75 Billion Reasons To Own Google »
Read More
								    				
							    			Are Only 2 Stocks of Stan’s On Sale?
Stanley Druckenmiller has an exemplary history and track record trading so we wanted to investigate whether any opportunities leap out in his current portfolio.
Which positions, if any, are underwater? And are there any diamonds in the rough now that are on sale?
In Druckenmiller’s Duquesne Family Office there are 75 stock positions as of September 30,
» Read more about: Are Only 2 Stocks of Stan’s On Sale? »
Read More
								    				
							    			1 Cash Cow with Massive Upside
CVS Health (NYSE:CVS) share price declined by over 23% over the past twelve months. Hurting shareholders was the recent leadership transition from CEO Karen Lynch to David Joyner, a shift that brought uncertainty to the company’s direction as investors questioned the company’s stability while facing ongoing challenges.
» Read more about: 1 Cash Cow with Massive Upside »
Read More
								    				
							    			Is It Finally Time to Buy Walgreens?
Walk into just about any town in America, and chances are you’ll spot a Walgreens. The pharmacy chain is one of the most ubiquitous retail brands in the country, with over 8,000 locations across the U.S. alone.
But while its storefronts are everywhere, the same can’t be said for investor confidence in its stock.
» Read more about: Is It Finally Time to Buy Walgreens? »
Read MoreThe Burst
								    				
							    			1 Massive Advantage Retail Investors Have Over Hedge Funds
Retail investors are usually playing catch-up and it’s no surprise why. They don’t have a research department, a Bloomberg Terminal on every desk, or a network of analysts and insiders feeding them information in real time. Hedge funds, with their armies of research analysts, data scientists, and software systems, are optimized to gain any edge possible.
» Read more about: 1 Massive Advantage Retail Investors Have Over Hedge Funds »
Read MoreThe Spotlight
								    				
							    			Has The Golden Age For Twilio Started?
Twilio is one of those companies that not many individuals know much about but which is used widely by over 300,000 businesses.
It essentially powers SMS communications so let’s say you’re a Dell or Shopify or Toyota and want to message your own audiences, you would sign up to Twilio to engage with them.
» Read more about: Has The Golden Age For Twilio Started? »
Read MoreThe Daily
Bharti Airtel shares jump 2.2% today; brokerages bullish after Q2 profit beats Street, ARPU rises — check target prices
Bharti Airtel Share Price Today: Brokerages shared bullish views with the telecom major’s Q2 FY26 showing higher profitability, premium subscriber additions, rising ARPU, and operational momentum across India and Africa.
Bharti Airtel added 1.3 million new subscribers sequentially in India
‘);
							$(‘#lastUpdated_’